The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholdings

10 Dec 2020 18:11

RNS Number : 3007I
LiDCO Group Plc
10 December 2020
 

 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Director / PDMR Shareholdings

 

LiDCO (AIM: LID), a leading supplier of hemodynamic monitoring solutions, makes the following announcement in respect of certain dealings in the Company's shares carried out by certain directors on 8 December 2020.

 

Exercise of certain share options

 

On 8 December 2020, the Company announced that the recommended cash offer made by Masimo LHC Limited ("Masimo") for the entire issued and to be issued share capital of LiDCO (the "Offer") had become unconditional in all respects. On the Offer becoming unconditional in all respects, certain Enterprise Management Incentive options ("EMI Options") granted under the Company's Share Option Plan over ordinary shares of 0.5 pence in the capital of the Company ("Shares") became exercisable, to the extent vested at such date.

 

The following directors have each submitted exercise instructions to the Company in respect of the EMI Options shown against their name below, and the relevant number of Shares have been issued and allotted to them in connection with such exercise:

 

Name of PDMR

Date of grant

Date of exercise

Exercise priceper Share

Resulting number of Shares

Matt Sassone

11 April 2017

8 December 2020

0.5 pence

2,200,000

Tim Hall

9 April 2019

8 December 2020

0.5 pence

2,000,000

29 April 2020

8 December 2020

0.5 pence

1,000,000

29 April 2020

8 December 2020

0.5 pence

787,500

 

EMI Options were exercised by other members of staff resulting in a further 3,568,533 Shares being issued and allotted. Admission of the 9,556,033 Shares arising from the exercise of EMI Options has been satisfied via the Company's block listing, application for which was announced on 26 November 2020.

 

The Shares arising from the exercise of EMI Options were issued on 10 December 2020 and immediately following their issue, the directors and other members of staff each sold all of their Shares to Masimo in accordance with their irrevocable commitments to do so in connection with the Offer.

 

Cash cancellation of certain share options

On the Offer becoming unconditional in all respects, certain non-tax-qualifying options ("Non-Qualifying Options") granted under the Company's Share Option Plan over Shares became exercisable, to the extent vested at such date.

 

Matt Sassone has agreed with Masimo to surrender the Non-Qualifying Options shown in the table below, in return for a cash cancellation payment made to him by Masimo of the "see-through value" of the Non-Qualifying Options (i.e. the aggregate value of the resulting Shares that he could have received by exercising his Non-Qualifying Options and selling them at the Offer price, less the aggregate cost of such exercise (being 0.5 pence per Share)):

 

Name of PDMR

Date of grant

Date of cash cancellation

Number of shares under Non-Qualifying Option

"See-through value" of Non-Qualifying Option

Matt Sassone

20 April 2018

8 December 2020

919,250

£105,713.75

9 April 2019

8 December 2020

2,000,000

£230,000.00

 

Non-Qualifying Options held by other members of staff over 2,365,038 shares were also surrendered in return for cash cancellation payments from Masimo with a total "see-through value" of £153,748.

 

Total voting rights and Rule 2.9 update

Following the exercise of EMI Options described above, the Company will have 253,730,941 Shares in issue, each carrying one voting right. There are no shares held in Treasury. The total number of voting rights in LiDCO is therefore 253,730,941. This number may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or a change in their interest in, LiDCO under the Disclosure and Transparency Rules or under Rule 8 of the Takeover Code.

 

Following the exercise of EMI Options and the cash cancellation of certain Non-Qualifying Options as described above, there are no other in-the-money options over Shares which are capable of exercise.

 

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 ("MAR"). Additional MAR disclosures regarding PDMR dealings are included below.

 

For further information:

 

LiDCO

Peter Grant (Non-Executive Chairman)

Matt Sassone (Chief Executive Officer)

Tim Hall (Chief Financial Officer)

 

Tel: +44 20 7749 1500

Smith Square Partners - Financial Adviser to LiDCO

John Craven

Matt Alexander

 

Tel: +44 20 3696 7260

 

N+1 Singer - Nominated Adviser and Broker to LiDCO

Aubrey Powell

George Tzimas

Tel: +44 20 7496 3600

 

 

 

 

 

 

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in one percent or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified.  An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s).  An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm  (London time) on the 10th Business Day following the commencement of the Offer Period and, if appropriate, by no later than 3.30 pm  (London time) on the 10th Business Day following the announcement in which any securities exchange offeror is first identified.  Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in one percent or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror.  A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8.  A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm  (London time) on the Business Day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Matt Sassone

 

2.

Reason for the notification

a)

Position/status

Chief Executive Officer

 

b)

Initial notification/ Amendment

 

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

LiDCO Group Plc

 

b)

LEI

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

Exercise of Enterprise Management Incentive option granted on 11 April 2017 over 2,200,000 Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£11,000

2,200,000

 

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable - single transaction

e)

Date of the transaction

8 December 2020

f)

Place of the transaction

Outside a trading venue

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

Sale of 2,200,000 Shares resulting from the exercise of an Enterprise Management Incentive Option 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£264,000

2,200,000

 

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable - single transaction

e)

Date of the transaction

10 December 2020

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

(1) Cash cancellation of a non-qualifying option granted on 20 April 2018 over 919,250 Shares

(2) Cash cancellation of a non-qualifying option granted on 9 April 2019 over 2,000,000 Shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£105,713.75

919,250

£230,000.00

2,000,000

 

d)

Aggregated information

 

Aggregated volume

Price

 

Price(s)

Volume(s)

£335,713.75

2,919,250

 

e)

Date of the transaction

8 December 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Tim Hall

 

2.

Reason for the notification

a)

Position/status

Chief Financial Officer

 

b)

Initial notification/ Amendment

 

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

LiDCO Group Plc

 

b)

LEI

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

(1) Exercise of an Enterprise Management Incentive option granted on 9 April 2019 over 2,000,000 Shares

(2) Exercise of an Enterprise Management Incentive option granted on 29 April 2020 over 1,000,000 Shares 

(3) Exercise of an Enterprise Management Incentive option granted on 29 April 2020 over 787,500 Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£10,000.00

2,000,000

£5,000.00

1,000,000

£3,937.50

787,500

 

d)

Aggregated information

 

Aggregated volume

Price

 

Price(s)

Volume(s)

£18,937.50

3,787,500

 

e)

Date of the transaction

8 December 2020

f)

Place of the transaction

Outside a trading venue

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

Sale of Shares resulting from the exercise of an Enterprise Management Incentive Option 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£454,500.00

3,787,500

 

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable - single transaction

e)

Date of the transaction

10 December 2020

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKKBKFBDDFBD
Date   Source Headline
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
22nd Jun 20123:05 pmRNSExercise of Share Options
13th Jun 201211:55 amRNSResult of AGM
13th Jun 20127:00 amRNSLaunch of the LiDCOrapid monitor in Japan
12th Jun 20127:00 amRNSAnnual Report and Accounts and Notice of AGM
29th May 20127:00 amRNSLiDCOrapid Registration in Japan
10th May 20127:00 amRNSLiDCO technologies highlighted in NHS report
4th May 20127:00 amRNSExercise of Share Options
25th Apr 201210:40 amRNSGrant of share option
24th Apr 20127:00 amRNSPreliminary Results
28th Mar 20123:10 pmRNSExercise of Share Option
23rd Feb 20127:00 amRNSTrading Update and Notice of Results and AGM
8th Feb 20124:31 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Jan 20127:00 amRNSLiDCO signs licensing agreement with CNSystems
12th Dec 20112:30 pmRNSExercise of a Share Option
7th Dec 20117:00 amRNSNHS Innovation Review
26th Oct 20117:00 amRNSInterim Results
12th Oct 20117:00 amRNSLiDCO monitor reduces surgical complications
24th Aug 201111:42 amRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNSPre- close trading update
29th Jul 20117:00 amRNSExercise of Share Options
28th Jul 20117:00 amRNSNotice of Results
20th Jul 20113:25 pmRNSDirector's Holdings
14th Jul 20114:22 pmRNSExercise of a Share Option / Director's Holdings
14th Jul 20117:00 amRNSLiDCO signs agreement with ICU Medical, Inc
29th Jun 201111:45 amRNSResult of AGM
29th Jun 20117:00 amRNSJapanese Registration and Supply Agreement
1st Jun 20112:00 pmRNSPosting of Annual Report and Notice of AGM
17th May 20117:00 amRNSIssue of Equity
21st Apr 201111:45 amRNSDirector/PDMR Shareholding
20th Apr 20114:20 pmRNSDirector/PDMR Shareholding
19th Apr 20117:00 amRNSGrant of Share Options
18th Apr 20117:00 amRNSPreliminary Results
18th Apr 20117:00 amRNSDirectorate Change
15th Apr 201111:45 amRNSHolding(s) in Company
21st Mar 20117:00 amRNSDistribution Contract
24th Feb 20117:00 amRNSTrading Update and Notice of Results and AGM
26th Oct 20107:00 amRNSInterim Results
26th Oct 20107:00 amRNSInterim Results
15th Oct 20107:00 amRNSLiDCO monitors link with GE Healthcare
23rd Aug 20107:00 amRNSIssue of Equity
17th Aug 20102:50 pmRNSPre-Close Trading Update
12th Aug 20107:00 amRNSNotice of Results
12th Jul 20109:00 amRNSDirector's Share Transaction
2nd Jul 20107:00 amRNSLiDCO study day receives RCN accreditation
29th Jun 201011:40 amRNSResult of AGM
7th Jun 20101:30 pmRNS2010 Annual Report and Accounts & Notice of AGM
4th Jun 20107:00 amRNSDirectors dealings and grant of options
10th May 20107:00 amRNSMultiparameter monitoring reduces risk in surgery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.